SEC Form 4 · accession 0001123292-16-002729
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Morgan Lam
Officer — Chief Scientific Officer
Period of report
Sep 13, 2016
Accepted (ET)
Sep 15, 2016 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.38 | Sep 13, 2016 | A | 100,000 | A | — | Sep 12, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable in 12 equal quarterly installments beginning on December 13, 2016.